Trial intelligence / Profile preview

Nebulized Hypertonic Saline in the Treatment of Bronchiolitis in Infants

NCT00151905Phase 3Completed

Sponsor
Sheikh Khalifa Medical City
Start
Nov 2003
Modality
Small Molecules, Device-based Delivery
Countries
2
01

Overview

Phase 3, randomised, double-blind trial of hypertonic saline in bronchiolitis (2 arms), sponsored by Sheikh Khalifa Medical City. Primary endpoint: Length of stay. Started Nov 2003; status: completed.

02

Drugs

hypertonic saline
03

Conditions

bronchiolitis

Beyond the preview

Go deeper on NCT00151905.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00151905.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call